Qube Research & Technologies (QRT)’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.62M Sell
655,729
-1,114,968
-63% -$7.86M 0.01% 1577
2026
Q1
$11.4M Buy
1,770,697
+280,957
+19% +$2.17M 0.01% 1199
2025
Q4
$12.2M Buy
1,489,740
+1,041,047
+232% +$9.4M 0.01% 1213
2025
Q3
$3.98M Buy
448,693
+10,855
+2% +$68.6K ﹤0.01% 1889
2025
Q2
$2.29M Buy
437,838
+210,288
+92% +$1.07M ﹤0.01% 2146
2025
Q1
$1.23M Buy
227,550
+51,336
+29% +$242K ﹤0.01% 2179
2024
Q4
$805K Buy
+176,214
New +$902K ﹤0.01% 2288
2024
Q3
Sell
-27
Closed -$75 3301
2024
Q2
$75 Hold
27
﹤0.01% 3458
2024
Q1
$67 Buy
+27
New +$65 ﹤0.01% 4202
2022
Q1
Sell
-42,169
Closed -$312K 2431
2021
Q4
$312K Buy
42,169
+11,762
+39% +$85.5K ﹤0.01% 1791
2021
Q3
$244K Buy
+30,407
New +$295K ﹤0.01% 1570

Other funds holding AVAH

Qube Research & Technologies (QRT)'s AVAH Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Aveanna Healthcare (AVAH) stake by 63% in Q2 2026, selling an estimated $7.86M and leaving 655,729 shares worth $5.62M. The position accounts for 0.01% of the portfolio, ranked #1577.

Qube Research & Technologies (QRT) first reported a position in AVAH in Q3 2021 and has held it in 11 quarters since. The position peaked at $12.2M in Q4 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Qube Research & Technologies (QRT) held 655,729 shares of Aveanna Healthcare worth $5.62M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,114,968 Aveanna Healthcare shares in Q2 2026, an estimated $7.86M.
  • Aveanna Healthcare made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1577 holding.
  • Qube Research & Technologies (QRT) first reported a position in Aveanna Healthcare in Q3 2021 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s Aveanna Healthcare position peaked at $12.2M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.